Approval · Notice of Compliance 1030 · 2000
CLINDASOL: Notice of Compliance 1030
Issued October 27, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1030
- Date
- October 27, 2000
- Company
- Stiefel Canada UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLINDASOL | 02242970 | Cancelled Post Market |
Medicinal ingredients
- CLINDAMYCIN PHOSPHATE 1 PER